Literature DB >> 23358915

No evidence of efficacy or evidence of no efficacy.

Marco A Arruda.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23358915     DOI： 10.1001/jamapediatrics.2013.1105

Source DB:  PubMed          Journal:  JAMA Pediatr        ISSN： 2168-6203            Impact factor:   16.193


× No keyword cloud information.
  10 in total

1.  Anti-reabsorptive agents in women with osteoporosis: determining statistical equivalence according to evidence-based methods.

Authors:  Andrea Messori; Valeria Fadda; Dario Maratea; Sabrina Trippoli; Claudio Marinai
Journal:  J Endocrinol Invest       Date:  2014-07-10       Impact factor: 4.256

2.  Harnessing the placebo effect in pediatric migraine clinic.

Authors:  Vanda Faria; Clas Linnman; Alyssa Lebel; David Borsook
Journal:  J Pediatr       Date:  2014-07-22       Impact factor: 4.406

3.  Biological drugs for the treatment of moderate-to-severe psoriasis by subcutaneous route: determining statistical equivalence according to evidence-based methods.

Authors:  Andrea Messori; Valeria Fadda; Dario Maratea; Sabrina Trippoli; Roberta Gatto; Mauro De Rosa; Claudio Marinai
Journal:  Clin Drug Investig       Date:  2014-08       Impact factor: 2.859

4.  Risk of intracranial haemorrhage in patients with atrial fibrillation treated with novel oral anticoagulants: testing the equivalence margins between dabigratran, rivaroxaban and apixaban.

Authors:  Andrea Messori; Dario Maratea; Valeria Fadda; Sabrina Trippoli
Journal:  Eur J Clin Pharmacol       Date:  2014-01-23       Impact factor: 2.953

Review 5.  Cognitive Behavioral Therapy for Pediatric Headache and Migraine: Why to Prescribe and What New Research Is Critical for Advancing Integrated Biobehavioral Care.

Authors:  Ashley M Kroon Van Diest; Scott W Powers
Journal:  Headache       Date:  2018-11-16       Impact factor: 5.887

6.  Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine.

Authors:  Scott W Powers; Christopher S Coffey; Leigh A Chamberlin; Dixie J Ecklund; Elizabeth A Klingner; Jon W Yankey; Leslie L Korbee; Linda L Porter; Andrew D Hershey
Journal:  N Engl J Med       Date:  2016-10-27       Impact factor: 91.245

7.  Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: a randomized clinical trial.

Authors:  Scott W Powers; Susmita M Kashikar-Zuck; Janelle R Allen; Susan L LeCates; Shalonda K Slater; Marium Zafar; Marielle A Kabbouche; Hope L O'Brien; Chad E Shenk; Joseph R Rausch; Andrew D Hershey
Journal:  JAMA       Date:  2013-12-25       Impact factor: 56.272

Review 8.  Emerging Pharmacological Treatments for Migraine in the Pediatric Population.

Authors:  Luigi Francesco Iannone; Francesco De Cesaris; Pierangelo Geppetti
Journal:  Life (Basel)       Date:  2022-04-05

Review 9.  Advances in pediatric pharmacology, therapeutics, and toxicology.

Authors:  Daniel Gonzalez; Ian M Paul; Daniel K Benjamin; Michael Cohen-Wolkowiez
Journal:  Adv Pediatr       Date:  2014-05-06

10.  The effects of industry sponsorship on comparator selection in trial registrations for neuropsychiatric conditions in children.

Authors:  Adam G Dunn; Kenneth D Mandl; Enrico Coiera; Florence T Bourgeois
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.